On February 21, the Hang Seng Index Company unveiled its latest quarterly review results, revealing a series of changes aimed at enhancing the dynamics of the index, with implementations scheduled to take effect after market closing on March 7, 2025. The anticipation surrounding these shifts has stirred interest among investors, particularly given the evolving landscape of the Hong Kong stock market.

In this review, the number of constituent stocks in the Hang Seng Index remained constant at 83, indicative of stability within the mainstay of the indexHowever, it is worth noting that substantial adjustments were made to several other indices, especially those reflecting the technology sector, which continue to attract significant market attention.

This quarterly review differed markedly from previous iterationsThe addition and removal of stocks was notable, reflecting both market sentiment and the performance of specific industriesAmong the flagship indices influenced by these changes are the Hang Seng Composite Index, the China Enterprises Index, and the Hang Seng Technology Index.

Starting with the China Enterprises Index, it retained its tally of 50 stocks but underwent minor alterations with the additions of ZTO Express (02057.HK) and Beigene (06160.HK), while China Biologic Products (01177.HK) and Li Ning (02331.HK) were removedThis inclusion of logistics and biotech firms underscores a trend towards focusing on firms demonstrating robust growth potential and market adaptability.

The Hang Seng Technology Index, pivotal in showcasing Hong Kong's burgeoning tech landscape, maintained a stable count of 30 stocks, yet welcomed Tencent Music (01698.HK) and Horizon Robotics (09660.HK) while parting ways with Oriental Select (01797.HK) and ZhongAn Online (06060.HK). This reiterates the market's growing appetite for technology-driven enterprises, particularly those that can navigate the complexities of innovation and consumer demands.

Moreover, the Biotech Index also preserved its size at 50, adapting with the inclusion of Ascletis Pharma (01302.HK) and the removal of Eddingpharm (01541.HK). This speaks volumes about the current trajectory of the biotech sector that remains central to Hong Kong's structural advancements in healthcare and related research.

As for the Hang Seng Composite Index, which previously indicated a trend of 'more in than out' in the earlier quarters of the year, it has now displayed a notable shift with a reduction in the number of stocks, dropping from 517 to 505. The adjustments saw 29 new entrants, such as Mao Geping (01318.HK), Youjia Innovation (02431.HK), WeiLung Flavor (09985.HK), and more, while 41 stocks were ousted, among them Nai Xue’s Tea (02150.HK) and Zhihu (02390.HK). This shift illustrates a critical transition in market dynamics, reflecting a recalibration towards companies deemed more favorable for investment.

Behind these index compositions lies a narrative dictated by the performance and potential of specific sectors

Advertisements

In recent years, technology sectors, particularly artificial intelligence, have garnered widespread attention, and the review clearly reflects this trend as tech stocks become central to portfolio adjustmentsNew entries predominantly stem from emerging technological firms or industry leaders symbolizing China's economic transition.

The positive margins of companies entering the indices illustrate a skew towards tech-driven enterprises engaged in cutting-edge sectors such as robotics, autonomous driving, medical technology, fintech, renewable energy, and biotechnologySpecific examples include the inclusion of Robotics’ Yujian (02432.HK) in the smart robotics sub-index, with advancements in commercial applications such as automated driving fostered by Horizon Robotics and Youjia Innovation.

In addition, smaller indices also saw a surge in tech representation with companies like SenseTime (00020.HK), a player in AI software, HealthChain (02587.HK) in digital healthcare, and Yisou (02550.HK), a digital content company, entering the frayPossible predictions regarding the average market capitalization of these businesses hint at a robust interest from investors in sectors that promise future growth.

Research reports from institutions like CICC align with these alterations, indicating a decrease in the weight of consumer stocks in the indices after these modificationsConversely, there has been an uptick in the financial and utility sectors, revealing the quarter's strategic movements aptly catering to the broader market demands.

One of the more insightful disclosures from the Hang Seng Index Company noted that, by the end of 2024, passive investments tracking the Hang Seng Index series would total an impressive 75.6 billion USD in asset valueMoreover, exchanges tracking the Hang Seng Index ETF are predicted to achieve around 31.49 billion USD, while those following state-owned enterprises and the tech index are estimated to reach approximately 6.81 billion USD and 22.08 billion USD respectively

Advertisements

Advertisements

Advertisements

Advertisements